{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:45:47Z","timestamp":1794357947294,"version":"4.9.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972299"],"award-info":[{"award-number":["81972299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672390"],"award-info":[{"award-number":["81672390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National Key Research and Development Plan of China","award":["2017YFC0910002"],"award-info":[{"award-number":["2017YFC0910002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Growing evidence indicates that the systemic inflammatory response plays an important role in cancer development and progression. Several inflammatory markers have been reported to be associated with clinical outcomes in patients with various types of cancer. This study was designed to evaluate the prognostic value of inflammatory indexes in patients with ampullary cancer (AC) who underwent pancreaticoduodenectomy (PD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed the data of 358 patients with AC who underwent PD between 2009 and 2018. R software was used to compare the area under the time-dependent receiver operating characteristic (ROC) curves (AUROCs) of the inflammation-based indexes, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), modified Glasgow Prognostic Score (mGPS), prognostic nutritional index (PNI) and prognostic index (PI), in terms of their predictive value for survival. The survival differences of these indexes were compared by the Kaplan-Meier method and univariate and multivariate analyses were performed to determine the prognostic factors of disease-free survival (DFS) and overall survival (OS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The estimated 1-, 2-, and 3-year OS and DFS rates were 83.9, 65.8, and 55.2% and 58.0, 42.8, and 37.8%, respectively, for the entire cohort. The survival differences were significant in terms of OS and DFS when patients were stratified by these inflammation-based indexes. The comparisons of the AUROCs of these inflammation-based indexes illustrated that NLR and PI displayed the highest prognostic value, compared to the other indexes. When NLR and PI were combined, NLR-PI showed even higher AUROC values and was identified as a significant prognostic factor for OS and DFS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Specific inflammatory indexes, such as NLR, PLR and dNLR, were found to be able to predict the OS or DFS of patients. As a novel inflammatory index, the level of NLR-PI, which can be regarded as a more useful prognostic index, exhibited strong predictive power for predicting the prognosis of patients with AC after the PD procedure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07482-0","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T22:03:06Z","timestamp":1602280986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy"],"prefix":"10.1186","volume":"20","author":[{"given":"Shuxin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaobin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2698-2757","authenticated-orcid":false,"given":"Shengping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,10]]},"reference":[{"key":"7482_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/MPA.0000000000000385","volume":"45","author":"MD Chandrasegaram","year":"2016","unstructured":"Chandrasegaram MD, Chen JW, Price TJ, Zalcberg J, Sjoquist K, Merrett ND. Advances in molecular pathology and treatment of Periampullary cancers. PANCREAS. 2016;45:32\u20139.","journal-title":"PANCREAS."},{"key":"7482_CR2","doi-asserted-by":"publisher","unstructured":"Ahn DH, Bekaii-Saab T. Ampullary cancer: an overview. Am Soc Clin Oncol Educ Book. 2014; 34:112\u20135. https:\/\/doi.org\/10.14694\/EdBook_AM.2014.34.112.","DOI":"10.14694\/EdBook_AM.2014.34.112"},{"key":"7482_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.suc.2018.12.001","volume":"99","author":"R Zheng-Pywell","year":"2019","unstructured":"Zheng-Pywell R, Reddy S. Ampullary cancer. Surg Clin North Am. 2019;99:357\u201367.","journal-title":"Surg Clin North Am"},{"key":"7482_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4251\/wjgo.v9.i10.407","volume":"9","author":"MD Chandrasegaram","year":"2017","unstructured":"Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, et al. Ampullary cancer of intestinal origin and duodenal cancer - a logical clinical and therapeutic subgroup in periampullary cancer. World J Gastrointest Oncol. 2017;9:407\u201315.","journal-title":"World J Gastrointest Oncol"},{"key":"7482_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12893-017-0220-3","volume":"17","author":"B Amr","year":"2017","unstructured":"Amr B, Shahtahmassebi G, Aroori S, Bowles MJ, Briggs CD, Stell DA. Variation in survival after surgery for peri-ampullary cancer in a regional cancer network. BMC Surg. 2017;17:23.","journal-title":"BMC Surg"},{"key":"7482_CR6","first-page":"1","volume":"1","author":"M Bonet","year":"2020","unstructured":"Bonet M, Rodrigo A, V\u00e1zquez S, Carrizo V, Vilardell F, Mira M. Adjuvant therapy for true ampullary cancer: a systematic review. Clin Transl Oncol. 2020;1:1\u20137.","journal-title":"Clin Transl Oncol"},{"key":"7482_CR7","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.3748\/wjg.v21.i18.5582","volume":"21","author":"DS Zhou","year":"2015","unstructured":"Zhou DS, Xu L, Luo YL, He FY, Huang JT, Zhang YJ, et al. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization. World J Gastroenterol. 2015;21:5582\u201390.","journal-title":"World J Gastroenterol"},{"key":"7482_CR8","volume":"12","author":"C He","year":"2017","unstructured":"He C, Lin X. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. PLoS One. 2017;12:e174769.","journal-title":"PLoS One"},{"key":"7482_CR9","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.ejca.2006.01.002","volume":"42","author":"BJ Rollins","year":"2006","unstructured":"Rollins BJ. Inflammatory chemokines in cancer growth and progression. Eur J Cancer. 2006;42:760\u20137.","journal-title":"Eur J Cancer"},{"key":"7482_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12885-019-5468-9","volume":"19","author":"M Shibutani","year":"2019","unstructured":"Shibutani M, Maeda K, Nagahara H, Fukuoka T, Matsutani S, Kimura K, et al. The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study. BMC Cancer. 2019;19:241.","journal-title":"BMC Cancer"},{"key":"7482_CR11","first-page":"14","volume":"32","author":"C Virchow","year":"1978","unstructured":"Virchow C, Strassburg J. Release of histamine from leukocytes. A comparison between allergic and intrinsic asthma and normal persons. Prax Klin Pneumol. 1978;32:14\u201328.","journal-title":"Prax Klin Pneumol"},{"key":"7482_CR12","first-page":"1","volume":"1","author":"Y Lv","year":"2019","unstructured":"Lv Y, Zhang S, Liu Z, Tian Y, Ning Liang JZ. Prognostic value of preoperative neutrophil to lymphocyte ratio is superior to systemic immune inflammation index for survival in patients with Glioblastoma. Clin Neurol Neurosurg. 2019;1:1\u201315.","journal-title":"Clin Neurol Neurosurg"},{"key":"7482_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1724600819834306","volume":"34","author":"W Kim","year":"2019","unstructured":"Kim W, Lim T, Park P, Choi S, Kim W. Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resection. Int J Biol Markers. 2019;34:123\u201331.","journal-title":"Int J Biol Markers"},{"key":"7482_CR14","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1007\/s12032-012-0226-8","volume":"29","author":"DS Wang","year":"2012","unstructured":"Wang DS, Luo HY, Qiu MZ, Wang ZQ, Zhang DS, Wang FH, et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol. 2012;29:3092\u2013100.","journal-title":"Med Oncol"},{"key":"7482_CR15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2147\/CMAR.S161398","volume":"10","author":"D Galun","year":"2018","unstructured":"Galun D, Bogdanovic A, Djokic KJ, Bulajic P, Loncar Z, Zuvela M. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country. Cancer Manag Res. 2018;10:977\u201388.","journal-title":"Cancer Manag Res"},{"key":"7482_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biom J. 2005;47:458\u201372.","journal-title":"Biom J"},{"key":"7482_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jso.25816","volume":"121","author":"XT Huang","year":"2020","unstructured":"Huang XT, Huang CS, Chen W, Cai JP, Gan TT, Zhao Y, et al. Development and validation of a nomogram for predicting overall survival of node-negative ampullary carcinoma. J Surg Oncol. 2020;121:518\u201323.","journal-title":"J Surg Oncol"},{"key":"7482_CR18","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/01616412.2018.1497271","volume":"40","author":"W Weng","year":"2018","unstructured":"Weng W, Chen X, Gong S, Guo L, Zhang X. Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival. Neurol Res. 2018;40:917\u201322.","journal-title":"Neurol Res"},{"key":"7482_CR19","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1245\/s10434-018-07115-8","volume":"26","author":"HB Li","year":"2019","unstructured":"Li HB, Zhao FQ, Zhou J. Prognostic Nomogram for disease-specific survival in patients with non-metastatic Ampullary carcinoma after surgery. Ann Surg Oncol. 2019;26:1079\u201385.","journal-title":"Ann Surg Oncol"},{"key":"7482_CR20","doi-asserted-by":"publisher","first-page":"22854","DOI":"10.18632\/oncotarget.15281","volume":"8","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Si G, Zhu F, Hui J, Cai S, Huang C, et al. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget. 2017;8:22854\u201362.","journal-title":"Oncotarget."},{"key":"7482_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mrrev.2018.03.002","volume":"776","author":"K Jayaramayya","year":"2018","unstructured":"Jayaramayya K, Balachandar V, Santhy KS. Ampullary carcinoma-a genetic perspective. Mutat Res. 2018;776:10\u201322.","journal-title":"Mutat Res"},{"key":"7482_CR22","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2147\/CMAR.S190545","volume":"11","author":"C He","year":"2019","unstructured":"He C, Zhang Y, Cai Z, Lin X. The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy. Cancer Manag Res. 2019;11:1391\u2013400.","journal-title":"Cancer Manag Res"},{"key":"7482_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3747\/co.v17i4.567","volume":"17","author":"G Kasymjanova","year":"2010","unstructured":"Kasymjanova G, MacDonald N, Agulnik JS, Cohen V, Pepe C, Kreisman H, et al. The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol. 2010;17:52\u20138.","journal-title":"Curr Oncol"},{"key":"7482_CR24","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1186\/s12885-018-4842-3","volume":"18","author":"F Wang","year":"2018","unstructured":"Wang F, He W, Jiang C, Guo G, Ke B, Dai Q, et al. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer. BMC Cancer. 2018;18:1102.","journal-title":"BMC Cancer"},{"key":"7482_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrc1586","volume":"5","author":"W Zou","year":"2005","unstructured":"Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer. 2005;5:263\u201374.","journal-title":"Nat Rev Cancer"},{"key":"7482_CR26","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1111\/bph.12559","volume":"171","author":"M Skinner","year":"2014","unstructured":"Skinner M, Philp K, Lengel D, Coverley L, Lamm Bergstr\u00f6m E, Glaves P, et al. The contribution of VEGF signalling to fostamatinib-induced blood pressure elevation. Brit J Pharmacol. 2014;171:2308\u201320.","journal-title":"Brit J Pharmacol"},{"key":"7482_CR27","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1038\/s41598-019-41289-9","volume":"9","author":"JU Lim","year":"2019","unstructured":"Lim JU, Yeo CD, Kang HS, Park CK, Kim JS, Kim JW, et al. Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion. Sci Rep. 2019;9:4721.","journal-title":"Sci Rep"},{"key":"7482_CR28","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1007\/s00464-016-5371-2","volume":"31","author":"L Peng","year":"2017","unstructured":"Peng L, Lin S, Li Y, Xiao W. Systematic review and meta-analysis of robotic versus open pancreaticoduodenectomy. Surg Endosc. 2017;31:3085\u201397.","journal-title":"Surg Endosc"},{"key":"7482_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4239463","volume":"2019","author":"T Kabir","year":"2019","unstructured":"Kabir T, Ye M, Mohd Noor NA, Woon W, Junnarkar SP, Shelat VG. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes after curative resection for hepatocellular carcinoma. Int J Hepatol. 2019;2019:1\u20139.","journal-title":"Int J Hepatol"},{"key":"7482_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. NATURE. 2002;420:860\u20137.","journal-title":"NATURE."},{"key":"7482_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/10408363.2011.599831","volume":"48","author":"KH Allin","year":"2011","unstructured":"Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48:155\u201370.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"7482_CR32","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805\u201312.","journal-title":"J Clin Invest"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07482-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T17:08:44Z","timestamp":1633885724000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07482-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7482"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07482-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-23444\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-23444\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-23444\/v2","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,10]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Sun Yat-sen University Cancer Center. The IRB number of the present study is 5010\u20132015-006. All procedures performed in the present study involving human participants were in accordance with the ethical standards of institutional and\/or national research committees and the 1964 Helsinki Declaration and its later amendments or similar ethical standards. Written informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"981"}}